Sign Out
Postmenopausal Osteoporosis: Risedronate is indicated for the treatment and prevention of osteoporosis in postmenopausal women. In postmenopausal women with osteoporosis, it reduces the incidence of vertebral fractures and a composite endpoint of no vertebral osteoporosis-related fractures.
Osteoporosis in Men: Risedronate is indicated for treatment to increase bone mass in men with osteoporosis.
